Stephen Mullennix Insider Trading $URGN UroGen Pharma Ltd.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephen Mullennix.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen Mullennix. Stephen Mullennix is Chief Operating Officer in UroGen Pharma Ltd. ($URGN).
Stephen Mullennix in UroGen Pharma Ltd.
Trading Symbol: URGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen Mullennix: Chief Operating Officer
Holdings: 10,229 shares
Latest Transaction: Apr 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Stephen Mullennix in UroGen Pharma Ltd.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 417 | 0 | 2,917 | |
Apr 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 24.35 | 145 | 3,531 | 10,084 | 10.2 K to 10.1 K (-1.42 %) |
Apr 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 417 | 0 | 10,229 | 9.8 K to 10.2 K (+4.25 %) |
Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 7,037 | |
Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 28.04 | 612 | 17,160 | 9,812 | 10.4 K to 9.8 K (-5.87 %) |
Feb 18 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 10,424 | 8.7 K to 10.4 K (+20.30 %) |
Feb 04 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Feb 04 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 29.41 | 15,000 | 441,150 | 15,000 | |
Jan 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,666 | 0 | 3,334 | |
Jan 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 29.26 | 684 | 20,014 | 8,665 | 9.3 K to 8.7 K (-7.32 %) |
Jan 28 2020 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,666 | 0 | 9,349 | 7.7 K to 9.3 K (+21.68 %) |
Nov 18 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 8,796 | |
Nov 18 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 26.00 | 608 | 15,806 | 7,683 | 8.3 K to 7.7 K (-7.33 %) |
Nov 18 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 8,291 | 6.5 K to 8.3 K (+26.93 %) |
Aug 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 10,555 | |
Aug 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 31.65 | 608 | 19,243 | 6,532 | 7.1 K to 6.5 K (-8.52 %) |
Aug 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 7,140 | 5.4 K to 7.1 K (+32.69 %) |
May 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,759 | 0 | 12,314 | |
May 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 37.98 | 608 | 23,092 | 5,381 | 6 K to 5.4 K (-10.15 %) |
May 16 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 1,759 | 0 | 5,989 | 4.2 K to 6 K (+41.58 %) |
Mar 07 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,034 | 0 | 14,073 | |
Mar 07 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Sell | S | 37.30 | 2,804 | 104,589 | 4,230 | 7 K to 4.2 K (-39.86 %) |
Mar 07 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Buy | M | 0.00 | 7,034 | 0 | 7,034 | 0 to 7 K |
Jan 29 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 29 2019 | URGN | UroGen Pharma Ltd. | Mullennix Stephen | Chief Operating Off ... | Option Exercise | A | 42.50 | 15,000 | 637,500 | 15,000 |
Page: 1